Literature DB >> 27197980

Paroxetine use during pregnancy and the risk of cardiac defects.

Anick Bérard1, Sonia Chaabane1, Flory T Muanda1, Takoua Boukhris1, Jinping Zhao1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27197980      PMCID： PMC4972175          DOI： 10.1111/bcp.12979

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  12 in total

1.  Field studies versus database studies on the risks and benefits of medication use during pregnancy: Distinct pieces of the same puzzle.

Authors:  Anick Bérard; Katherine L Wisner; Stefanie Hultzsch; Christina Chambers
Journal:  Reprod Toxicol       Date:  2016-02-10       Impact factor: 3.143

2.  Meta-analysis requires independent observations and freedom from bias.

Authors:  Michael B Bracken
Journal:  Br J Clin Pharmacol       Date:  2016-03-23       Impact factor: 4.335

3.  Variable selection for propensity score models.

Authors:  M Alan Brookhart; Sebastian Schneeweiss; Kenneth J Rothman; Robert J Glynn; Jerry Avorn; Til Stürmer
Journal:  Am J Epidemiol       Date:  2006-04-19       Impact factor: 4.897

4.  Paroxetine exposure during pregnancy and the risk of cardiac malformations: what is the evidence?

Authors:  Anick Bérard
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-03

5.  Antidepressant use in pregnancy and the risk of cardiac defects.

Authors:  Anick Bérard; Sonia Chaabane; Takoua Boukhris
Journal:  N Engl J Med       Date:  2014-09-18       Impact factor: 91.245

6.  Paroxetine use during pregnancy and the risk of cardiac defects.

Authors:  Anick Bérard; Sonia Chaabane; Flory T Muanda; Takoua Boukhris; Jinping Zhao
Journal:  Br J Clin Pharmacol       Date:  2016-05-20       Impact factor: 4.335

Review 7.  The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.

Authors:  Anick Bérard; Noha Iessa; Sonia Chaabane; Flory T Muanda; Takoua Boukhris; Jin-Ping Zhao
Journal:  Br J Clin Pharmacol       Date:  2016-01-26       Impact factor: 4.335

8.  First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies.

Authors:  Keele E Wurst; Charles Poole; Sara A Ephross; Andrew F Olshan
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-03

9.  Antidepressant use in pregnancy and the risk of cardiac defects.

Authors:  Krista F Huybrechts; Kristin Palmsten; Jerry Avorn; Lee S Cohen; Lewis B Holmes; Jessica M Franklin; Helen Mogun; Raisa Levin; Mary Kowal; Soko Setoguchi; Sonia Hernández-Díaz
Journal:  N Engl J Med       Date:  2014-06-19       Impact factor: 91.245

10.  Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study.

Authors:  Espen Jimenez-Solem; Jon Traerup Andersen; Morten Petersen; Kasper Broedbaek; Jonas Krogh Jensen; Shoaib Afzal; Gunnar H Gislason; Christian Torp-Pedersen; Henrik Enghusen Poulsen
Journal:  BMJ Open       Date:  2012-06-18       Impact factor: 2.692
View more
  1 in total

1.  Paroxetine use during pregnancy and the risk of cardiac defects.

Authors:  Anick Bérard; Sonia Chaabane; Flory T Muanda; Takoua Boukhris; Jinping Zhao
Journal:  Br J Clin Pharmacol       Date:  2016-05-20       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.